跳至主要内容
临床试验/NCT01528371
NCT01528371已完成不适用

The Effect of Low Dose of Midazolam on Blood Pressure and Anxiety Scale in White-coat Hypertensive Dental Patients

Okayama University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Blood pressure

研究概览

简要总结

Intravenous sedation was used for dealing with transient hypertension, so-called white-coat hypertension, before dental treatment. Midazolam used as a sedative also has antianxiety effect, and the mechanism is guessed that it minimizes patients' stress, resulting in the stability of blood pressure. The purpose of this randomized controlled trial (RCT) is to evaluate the effect of low dose of midazolam on blood pressure and anxiety scale in white-coat hypertensive dental patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • SBP>=140mmHg or DBP>=90mmHg measuring when the patient sits on dental chair and has settled down for 5 minutes among dental outpatients scheduling intravenous sedation with American Society of Anesthesiologists physical status I or II.

排除标准

  • Uncontrolled or unstable hypertension
  • Secondary hypertension such as hyperthyroidism and pheochromocytoma
  • Taking sympathomimetic drugs
  • Contraindication of midazolam such as myasthenia gravis and acute narrow-angle glaucoma
  • A pregnant woman or during lactation period
  • Psychiatric disorder such as schizophrenia
  • Not having intelligence enough to read, understand and write a Japanese version of STAI
  • Judged unsuitable by a researcher

研究组 & 干预措施

Midazolam

Active Comparator

Intravenous administration of midazolam at dose of 0.02mg/kg

干预措施: Midazolam (Drug)

NSS

Placebo Comparator

Intravenous administration of saline solution at dose of 0.004ml/kg as a placebo drug

干预措施: Normal Saline Solution (NSS) (Drug)

结局指标

主要结局

Blood pressure

时间窗: Until 10 minutes after drug administration

Heart rate

时间窗: Until 10 minutes after drug administration

Oxygen saturation

时间窗: Until 10 minutes after drug administration

次要结局

  • Visual analog scale about anxiety to dental treatment(10 minutes after drug administration)
  • Sedation level(10 minutes after drug administration)
  • Japanese version of STAI(10 minutes after drug administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yoshihisa Watanabe

Department of Dental Anesthesiology and Special Care Dentistry,Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Okayama University

研究点 (1)

Loading locations...

相似试验